Subscribe! Enter your email to join The Caplet today!

Rinfocan- Prescription Drug Information for Canadians

Heart Health / Stroke Prevention Congestive Heart Failure Calcium Channel Blockers Hypertension Stroke Prevention	Psychiatry Antidepressants- the SSRI's Attention Deficit/ Hyperactivity Sleep and Aging
Neurology ReQuip- New safety info Multiple Sclerosis Parkinson's Disease Epilepsy Tasmar- sales suspended	Endocrinology (hormones) Diabetes- non insulin dependent Estrogen replacement therapy Premarin patient information Thyroid Replacement Menopause
Gastroenterology Crohn's / Colitis	Infectious Diseases Anthrax Herpes Update (shingles)  Herpes(shingles)  Tuberculosis
Medicinal Herbs Herbs and blood coagulation St. Johns Wort drug interactions Medicinal Herbs	Miscellaneous Chronic pain management

Herbs Which May Affect Coagulation Click Here for details

From the NewsWire

Early Initiation of Treatment Delays Development of Multiple Sclerosis

The results of a clinical trial examining the efficacy
of interferon-beta-1a (Avonex ) in patients at high
risk of developing clinically definite multiple
sclerosis (CDMS) were reported during the Late
Breaking News: MS Platform Session held May 1,
2000. at the 52nd Annual Meeting of the American
Academy of Neurology, San Diego. California.
In an interview after the session. Dr. Paul
O'Connor. a Canadian CHAMPS investigator,
stated, "These interesting and exciting results
suggest that interferons work best in MS when
given earlier rather than later in the disease,"